Electronic packaging for medication, system and method for manufacturing electronic packaging for medication

Abstract

The invention relates to electronic packaging for medication, comprising a foldable packaging unit (10) having recesses (14) and stamped regions (15). The recesses (14) are designed to receive a blister (2). The medication packaging also comprises an electronic label (30) having an electronics unit (33) and conductor tracks (34) which are formed at a distance from one another. The label (30) is coupled to the packaging unit (10) such that at least one conductor track (34) of the label (30) is associated with a corresponding stamped region (15) of the packaging unit (10) and the corresponding conductor track (34) crosses the associated stamped region (15) of the packaging unit (10) at least in some sections. The packaging unit (10) also comprises an adhesive layer (12) and a cover layer (13), which covers the adhesive layer (12) in a specified manner. The adhesive layer (12) can be exposed by removing the cover layer (13), and the packaging unit (10) can be adhesively bonded to itself by folding along the fold line (17) such that the recesses (14) and the stamped regions (15) can be arranged one over the other, with respect to a stacking direction (R) of the medication packaging, and overlap at least in some sections.

Description

[0001] P2024,0686 WO N / 24008P-WO September 2, 2025

[0002] - 1 -

[0003] Description

[0004] Electronic drug packaging, system and method for manufacturing electronic drug packaging

[0005] The present invention relates to an electronic drug packaging and a method for manufacturing such packaging, which enables reliable, electronically detectable drug dispensing in a simple and cost-effective manner. The invention further relates to a system comprising one or more containers and an electronic drug packaging.

[0006] Labels can serve for authorization or proof of origin and are used wherever it is necessary to identify or verify objects. For example, labels are used on medication packaging to provide necessary information. In the field of medication management, it is useful to monitor medication intake in a controlled manner, for example, to adhere to a prescribed medication plan.

[0007] The invention aims to provide an electronic drug packaging and a method for manufacturing an electronic drug packaging, each enabling reliably detectable drug withdrawal in a simple and cost-effective manner.

[0008] The problem is solved by the features of the independent patent claims. Advantageous further developments are specified in the respective dependent claims.

[0009] According to one aspect of the invention, an electronic drug packaging comprises a foldable packaging unit with a carrier layer having a plurality of recesses and die-cut areas formed opposite each other in the carrier layer with respect to a fold line of the packaging unit. The recesses are each designed to receive a blister pack. The drug packaging further comprises an electronic label having a carrier layer, an electronic unit, and a plurality of conductive traces. P2024,0686 WO N / 24008P-WO 2 September 2025

[0010] - 2 - which are spaced apart from each other. The label is coupled to the carrier layer of the packaging unit in such a way that at least one conductor track of the label is assigned to each die-cut area of ​​the packaging unit, and the respective conductor track crosses the assigned die-cut area of ​​the packaging unit at least partially. The packaging unit also has an adhesive layer that covers a surface of the carrier layer of the packaging unit in a predetermined manner. The packaging unit also has a covering layer that covers the adhesive layer in a predetermined manner, so that the adhesive layer can be exposed by peeling off the covering layer, and the packaging unit can be glued to itself by folding along the fold line, and the cutouts and die-cut areas can be arranged one above the other with respect to a stacking direction of the drug packaging and overlap at least partially.

[0011] The described electronic medication packaging enables reliable and cost-effective medication dispensing. This packaging provides a smart envelope or intelligent pouch for medications, allowing electronic monitoring of medication removal. Medications are arranged within the packaging unit and inserted into designated compartments. This electronic medication packaging can also be referred to as smart medication packaging or a smart wallet.

[0012] The drug packaging can be configured to hold, for example, four, eight, or more medications stored in containers such as syringes or vials, and to electronically monitor their removal. Accordingly, the packaging unit has four or eight cutouts and die-cut areas, and the label has four or eight conductive loops or traces. Alternatively, instead of multiple cutouts and die-cut areas or traces, the drug packaging can also be configured for only one medication container. In this case, the packaging unit has one cutout and an opposing die-cut area, and the label includes at least one conductive trace that crosses the die-cut area. However, it is more common, and therefore preferred, to package multiple medications in one drug packaging. P2024,0686 WO N / 24008P-WO 2 September 2025

[0013] - 3 - stored, so that the invention is described in the following description predominantly with regard to a plurality of recesses, punched areas, conductor tracks and / or medications.

[0014] Regarding folded drug packaging containing blister packs, when a drug is ejected from its cavity or blister, it passes through the corresponding perforated area of ​​the packaging unit, causing damage or a break in the associated conductive trace. This can be detected by the electronic unit as a change in resistance or conductivity of the conductive trace. Upon such an event, the electronic unit stores, for example, a timestamp and a positional information indicating from which cavity the drug was removed. The electronic unit is specifically designed to detect and record any break or change in the conductive traces as an event.The stored events can then be accessed using a reading device, such as an RFID reader or a smartphone with the necessary reading capability. This allows for verification of adherence to a prescribed medication plan.

[0015] The cutouts are formed primarily by die-cutting and are realized as perforations or cutouts in the carrier layer of the packaging unit. The die-cut areas are to be understood as areas or sections of the carrier layer of the packaging unit that are die-cut, but do not necessarily include a completely cut-out area. The die-cuts in the die-cut areas create predetermined material weakenings, which can, in particular, form a predetermined perforation or perforation pattern, so that the areas surrounding the die-cuts can be released and separated from the carrier layer of the packaging unit by simple pressure or tension. This typically occurs when the medication stored in the packaging unit is pushed out.

[0016] The fold line can be incorporated as a physical element in the carrier layer of the packaging unit and can be designed, for example, as a crease, a printed and / or embossed line. Alternatively, the fold line can also be a virtual line or axis. P2024,0686 WO N / 24008P-WO 2 September 2025

[0017] - 4 - show the fold lines along which the packaging unit is to be folded in order to align the cutouts over the respective corresponding die-cut area. Preferably, the fold line is visible to the user and is therefore formed as a physical element in the carrier layer of the packaging unit.

[0018] The packaging unit preferably comprises two sections of a common material web designed to be stacked on top of each other. Alternatively, the packaging unit can be non-foldable and, for example, have two separate sections to be stacked on top of each other. According to such an embodiment, the packaging unit would have a first section with a carrier layer comprising a plurality of cutouts. The packaging unit comprises a second section with a carrier layer comprising a plurality of die-cut areas designed to correspond to the cutouts of the first section. Accordingly, the packaging unit does not require a fold line, and the sections can be stacked and glued on top of each other without folding. The packaging unit has an adhesive layer on the first and / or the second section, which covers a predetermined surface of the respective carrier layer.The packaging unit can be glued together by peeling off the covering layer, exposing the adhesive layer, and arranging and gluing the two sections together, so that the cutouts and the punched areas can be arranged on top of each other in a stacking direction of the drug packaging and overlap at least partially.

[0019] According to a further aspect of the invention, an electronic drug packaging comprises a packaging unit with a carrier layer having a plurality of recesses arranged side by side in the carrier layer with respect to a lateral extent of the packaging unit. The recesses are each designed to receive a blister or a container. The drug packaging also comprises an electronic label having a carrier layer, an electronic unit, and a plurality of conductive traces spaced apart from one another. The label comprises a plurality of die-cut areas arranged side by side with respect to a lateral extent of the label, corresponding to the recesses of the packaging unit. P2024,0686 WO N / 24008P-WO 2 September 2025

[0020] - 5 - are. Each die-cut area of ​​the label is assigned at least one conductor track, and each conductor track crosses the assigned die-cut area at least partially. The label and / or the packaging unit has an adhesive layer that covers a surface of the associated carrier layer of the packaging unit or the label in a predetermined manner. The adhesive layer is in turn covered with a predetermined covering layer, so that by peeling off the covering layer, the adhesive layer can be exposed and the packaging unit can be bonded to the label, so that the cutouts and the die-cut areas can be arranged one above the other with respect to a stacking direction of the drug packaging and overlap at least partially.

[0021] In the following description, the invention is primarily described using a foldable packaging unit as an example. However, it should be noted that the respective features and properties of the drug packaging are also transferable to non-foldable packaging units, provided that the respective features and properties do not necessarily interact with a fold line or a folding process.

[0022] According to a preferred improved version of the drug packaging, the adhesive layer of the packaging unit is designed such that, after removing the outer layer and folding along the crease line, the carrier layer of the packaging unit can be bonded to itself at room temperature. The drug packaging is thus cold-sealable and does not require heat sealing, which necessitates a relatively high heat input for sealing and can adversely affect the medication stored in the packaging. Heat sealing, for example, involves sealing a package by melting a hot-melt adhesive. However, some active ingredients, such as liquids filled into syringes and vials, cannot withstand such a heat-sealing process because the active ingredient is particularly sensitive to temperature. At the very least, their efficacy is at high risk.The medication packaging is therefore particularly suitable for the reliable storage and controlled dispensing of heat-sensitive medications. Furthermore, the medication packaging can also be used for other medications, for example, those that are not heat-sensitive. P2024,0686 WO N / 24008P-WO 2 September 2025.

[0023] - 6 -

[0024] The adhesive layer can, for example, be applied to the inside of the packaging unit's carrier layer, which includes the cutouts. The electronic label is then, for example, placed on the non-adhesive inside of the packaging unit's carrier layer, specifically affixed to the die-cut areas. Folding brings the adhesive and non-adhesive sides together, bonding them without requiring additional heating elements or risking adverse temperature effects.

[0025] The electronic label is therefore preferably irreversibly embedded in the folded packaging unit, so that manual access to the electronic unit is not possible without causing damage. Accordingly, the electronic label is preferably applied to a surface of the carrier layer of the packaging unit that faces inwards after folding or away from the environment. Alternatively, the electronic label can be attached to an outer surface of the packaging unit, wherein the outer surface is a surface of the carrier layer of the packaging unit that faces outwards after folding or towards the environment.

[0026] According to a further development of the drug packaging, the adhesive layer completely covers the surface of the carrier layer of the packaging unit, with the surface forming an inner side of the packaging unit that is located on the inside after the packaging unit is folded and self-adhesive. The packaging unit has, for example, a first and a second section that form opposite sides of the carrier layer with respect to the fold line. The packaging unit is designed and / or coupled with the label in such a way that, after the packaging unit is folded and self-adhesive, the label is positioned between the two sections of the packaging unit and is securely and protected within them.

[0027] According to a further preferred embodiment of the drug packaging, the covering layer comprises a first, inner die-cut and a second, outer die-cut that surrounds the first die-cut. Thus, an inner covering section and an outer covering section are formed, creating an intermediate covering frame. The covering layer with its die-cuts is in accordance with the label P2024,0686 WO N / 24008P-WÖ 2 September 2025

[0028] - 7 - designed such that the inner covering section is smaller in area than the label. Preferably, the inner covering section is identical in shape to an outer contour of the label. After the inner covering section has been removed, the label can be adhered to the packaging unit in such a way that the label covers at least part of the covering frame. The label thus lies on the covering frame, in particular in an adhesive manner.

[0029] The outer liner can be peeled off separately, particularly at a later stage when the medication is being placed in the packaging, so that after the medication is inserted, the packaging unit can be folded and sealed to itself. The label, which is attached to the liner, remains inside the packaging unit and is reliably and securely embedded within it. The liner is made of a material such as silicone paper and can also be referred to as a liner. The liner covers the adhesive layer before it is exposed for use. The label may also have an adhesive layer on its underside, designed to be adhered to the backing layer of the packaging unit.

[0030] According to a further development of the drug packaging, the packaging unit has an opening in the area of ​​the cutouts and / or die-cut areas, which incorporates a child-resistant component to prevent the removal of the medication from the packaging. The drug packaging can thus be designed to be particularly secure. Such a child-resistant feature can be implemented and integrated into the product structure of the drug packaging, similar to known devices such as "Dosepak" from Westrock or "Key-Pak" from Keystone.

[0031] The opening section is, for example, pre-marked with a color code and die-cut. On the outside of the packaging unit, this section is designed to be pushed through to trigger a pull tab or tear strip on the opposite side. Once pulled, this strip reveals the inner side of the blister and the label, allowing the medication to be dispensed from the packaging. (See also P2024,0686 WO N / 24008P-WÖ 2 September 2025)

[0032] - 8 - each medication or associated recess and punched area may be provided with its own opening cut as a child safety feature.

[0033] Alternatively or additionally, the medication packaging can be placed inside a further outer packaging envelope, which incorporates a child-resistant closure. The opening cutout should therefore be provided as a cardboard die-cut on the outer packaging envelope, so that after pressing the cutout, the medication packaging is released as an inner packaging envelope and can be pulled out of the outer envelope. After a tablet or medication has been removed from the inner packaging envelope, the inner packaging envelope is placed back into the outer packaging envelope.

[0034] According to a further development of the drug packaging, the packaging unit has additional fold lines along which it can be folded. These fold lines can be understood as real or virtual elements, as previously described. The covering layer has one or more perforations that penetrate the covering layer and are designed to align with the fold lines and the conductive tracks, so that after the covering layer is peeled away from the adhesive layer of the packaging unit, a predetermined section of the covering layer remains on the packaging unit, providing crease reinforcement for the conductive tracks in the area of ​​one or more fold lines.

[0035] According to a further development of the drug packaging, the electronic label comprises a printed circuit board and / or an RFID transponder with an RFID chip and an antenna structure, which are interconnected and linked to the circuit traces. The electronic unit is, for example, designed as a PCB (printed circuit board) with integrated RFID and / or NFC functionality and is in signal contact with the label's circuit traces. Alternatively or additionally, the electronic unit can be configured to enable signal communication via Bluetooth or GSM as a data transmission technology. The electronic unit can, in particular, be designed as a circuit board populated with electronic components. This includes, among other things, a chip or microcontroller. For example, the electronic unit also includes resistors, a battery, P2024,0686 WO N / 24008P-WO 2 September 2025

[0036] - 9 - a quartz clock and / or an antenna structure, forming what is known as an integrated circuit board. The electronic unit can be partially or completely printed. For example, the electronic unit can be a partially printed circuit coupled with other non-printed components, such as a microcontroller. The electronic drug packaging thus provides sensor technology that allows each individual removal of medication from a single cavity to be monitored. During medication removal, data such as a timestamp and cavity assignment can be automatically stored in the electronic unit and read using transmission technologies such as RFID, Bluetooth, or GSM.

[0037] According to a further development of the drug packaging, the label is designed to fit the packaging unit in such a way that it at least partially covers one or more die-cut areas of the packaging unit, and the label's backing layer has a perforation in the respective covering section. The label is preferably designed with a surface area such that its backing layer precisely covers the die-cut areas of the packaging unit's backing layer. Accordingly, the conductive traces are preferably formed entirely on the label's backing layer, for example, printed on it.Alternatively, the label can be designed in coordination with the packaging unit so that the conductor tracks contact the electronic unit and are also printed or formed on the carrier layer of the packaging unit, so that they directly or indirectly cross the die-cut area that must be opened when removing medication.

[0038] Furthermore, the label can have a predefined perforation structure in the respective covering section, which, when viewed from above, creates a ring-shaped or flat material weakening of the label's backing layer. Because the label has flat, ring-shaped perforation structures over the die-cut areas of the packaging's backing layer, this contributes to a directed and simplified opening dynamic of the respective section when removing medication. P2024,0686 WO N / 24008P-WO 2 September 2025

[0039] - 10 -

[0040] The backing layer of the packaging unit is preferably made of cardboard or includes a cardboard element that may be pre-cut and printed. This backing layer can also be referred to as the packaging unit's carrier material. It provides a stable surface for the electronic label and the medication to be inserted, and, when folded, forms a sturdy and reliably protective envelope or pocket. Alternatively or additionally, a paper or plastic element, such as a film, can be used as the backing layer of the packaging unit, provided it is foldable and allows for the proper use of the medication packaging. The label's backing layer can be made of film, such as PET film, or include a film element. This backing layer can also be referred to as the label's carrier material.Alternatively or additionally, a different material or material combination, such as a paper or cardboard element, can be used as the label's backing layer, provided this allows for the label's proper use and, in particular, its coupling to the packaging unit. The conductive traces and / or the electronic unit can be formed by printing or etching onto the label's backing layer and / or the packaging unit's backing layer. Alternatively or additionally, the conductive traces can be pre-formed by primary forming or sintering and / or laser cutting. The label can also include conductive components or adhesive layers that couple the electronic unit to one or more conductive traces.

[0041] It is a finding related to the present invention that, particularly with regard to heat-sensitive medications, there is a need for reliable sealing and monitoring of the medications. Due to the described product structure, the embodiments of the medication packaging enable an electronic dispensing monitoring function, which is particularly suitable for cases where processing by the customer or user, such as a doctor or pharmacist, is to take place at room temperature without the input of additional heat. Assembly can proceed similarly to packaging without an electronic monitoring function.

[0042] A fully or predominantly adhesive design of the drug packaging enables a particularly reliable sealing of the label and the medication in P2024,0686 WO N / 24008P-WO 2 September 2025

[0043] - 11 - the folded envelope. Thus, unlike sealing, where only an adhesive layer is bonded to a non-adhesive layer at the edges, the adhesive strength can be increased. Furthermore, full or predominant adhesive lamination is less complex to manufacture than partial adhesive lamination. A cardboard backing material or carrier layer of the packaging unit can be coated with a specific adhesive, or alternatively, a cardboard with a fully laminated adhesive can be obtained cost-effectively from a cardboard supplier. No additional adhesive inhibitors or weakeners are required to reduce the adhesive strength of the existing adhesive layer.

[0044] The covering layer or liner can be specifically designed to meet its intended functions and reliably cover the adhesive layer until use, thus eliminating exposed adhesive surfaces that could come into unwanted contact with each other or with other materials during the manufacturing process, transport, or assembly, causing undesirable adhesion. In particular, a predefined liner section can be designed as a covering frame that remains within the folded and glued packaging unit, simplifying handling when coupling the label and packaging unit and providing kink resistance for critical areas of the conductive traces.

[0045] The described drug packaging therefore also contributes to beneficial process capability and processability.

[0046] According to a further aspect of the invention, a system comprises at least one container with a drug, a blister for the container, and an embodiment of the previously described electronic drug packaging. The container is arranged in the blister, and the blister is arranged in a recess of the packaging unit. In particular, after removal of the covering layer and folding along the fold line, the packaging unit is glued to itself, such that the recesses and the die-cut areas of the packaging unit are arranged one above the other with respect to a stacking direction of the drug packaging and overlap at least partially. The blister particularly comprises a cavity in which the container is securely arranged, such that the container is positioned between the blister and the folded and glued packaging unit. P2024,0686 WO N / 24008P-WO 2 September 2025

[0047] - 12 - is embedded. On the side opposite the blister or in the die-cut area, the label is arranged and / or a liner section is provided, each of which prevents the medication from sticking to the self-adhesive layer of the packaging unit. Such a piece of liner can form part of the adhesive cover, which protects the adhesive until the time of assembly or folding and sealing.

[0048] Since the described system comprises an embodiment of the previously described electronic drug packaging, the described properties and features of the electronic drug packaging are also disclosed for the system, and vice versa. The system preferably comprises several containers whose contents represent a drug. Alternatively or additionally, drugs such as tablets can also be provided that are not stored in a container but can be used in a blister pack within the electronic drug packaging. For example, if a liquid drug is to be administered, it is typically stored in a pharmaceutical container, such as a syringe, vial, or injection bottle, until administration.

[0049] According to a further aspect of the invention, a method for manufacturing electronic drug packaging comprises providing a foldable packaging unit with a carrier layer that includes a plurality of recesses and die-cut areas formed opposite each other in the carrier layer with respect to a fold line of the packaging unit. The recesses are each designed to receive a drug blister pack. The packaging unit further comprises an adhesive layer that covers a surface of the carrier layer of the packaging unit in a predetermined manner, and also has a covering layer that covers the adhesive layer in a predetermined manner. The method further comprises providing an electronic label that has a carrier layer, an electronic unit, and a plurality of conductive traces that are spaced apart from one another.The label provision may include providing the label's carrier layer as a foil element. The conductive traces may be printed on the foil element and / or the carrier layer of the packaging unit. The process also includes coupling the label to the carrier layer of the packaging unit, such that at least one conductive trace of the P2024,0686 WO N / 24008P-WO 2 September 2025 is provided to each die-cut area of ​​the packaging unit.

[0050] - 13 -

[0051] is assigned to the label and the respective conductor track crosses the assigned die-cutting area of ​​the packaging unit at least partially.

[0052] The described method is specifically designed for manufacturing an embodiment of the previously described electronic drug packaging. Therefore, the described properties and features of the electronic drug packaging are also disclosed for the method, and vice versa.

[0053] The process may further include peeling off the covering layer and exposing the adhesive layer. Subsequently, the packaging unit is folded along the fold line, bonding it to itself, and the cutouts and die-cut areas are aligned one above the other with respect to a stacking direction of the drug packaging, so that they overlap at least partially. The folding and bonding of the packaging unit is carried out according to standard operating procedures after the drug(s) in designated blisters have been placed in the cutouts of the packaging unit.

[0054] According to a further development of the method, providing the packaging unit and coupling the label to the packaging unit includes die-cutting the covering layer and forming a first, inner die-cut and a second, outer die-cut that surrounds the first die-cut, so that an inner covering section and an outer covering section are formed, creating an intermediate covering frame. The covering layer and its die-cuts are designed to match the label, such that the inner covering section is smaller in area than the label. The method further includes peeling off the inner covering section, thereby partially exposing the adhesive layer of the packaging unit, and subsequently applying the label to the exposed part of the adhesive layer, so that the label is positioned on the covering frame and covers it at least partially.

[0055] The self-sealing of the packaging unit can further involve peeling off the outer covering section, thereby exposing the adhesive layer of the packaging unit. Subsequent folding of the packaging unit along the fold line will achieve P2024,0686 WO N / 24008P-WO 2 September 2025

[0056] - 14 - the packaging unit is glued to itself, so that the label arranged on the covering frame is embedded inside the packaging unit.

[0057] The described process can further include processing the packaging unit or the packaging unit's carrier material in the form of a cardboard layer. The layered structure of the pharmaceutical packaging features two types of die-cuts: die-cuts that extend through all layers, particularly the cardboard layer, and die-cuts located where blister cavities protrude through the cardboard layer in the finished product. These die-cuts surround an area that is removed in a process step. Pre-cuts, for example of the liner, ensure that the liner is not removed across the entire surface, but rather selectively in specific areas. This offers process-related advantages, as the bonding of various components during the manufacturing process can occur in several steps and at different locations.

[0058] In one step, the liner is peeled back from the cardboard layer where the label with conductive traces is to be applied. This corresponds to the inner covering section described above. Two adjacent die-cuts are provided for this purpose: the inner and outer liner die-cuts, which form a covering frame around the label that will later be applied. The liner is peeled back along the inner die-cut contour. The liner or covering frame is slightly larger than the label and compensates for inaccuracies during label application, allowing for a small degree of positioning leeway when applying the label and preventing any unwanted exposed adhesive areas afterward.

[0059] If, after the label is applied, conductive traces run over creases in the cardboard layer, additional perforations are preferably provided in the liner, or the described perforations are adapted accordingly so that a portion of the liner remains at the creases and contributes to the stability of the conductive traces in the crease area. In a subsequent process step, to form a configuration of the system described above, one or more blisters are inserted onto the section of the cardboard layer that has the cutouts, and the liner is peeled off. In the label area, the liner peeling now takes place at the outer perforation, so that in the area around P2024,0686 WO N / 24008P-WÖ 2 September 2025

[0060] - 15 - the label around the liner frame remains. The cardboard is folded and glued to itself at room temperature.

[0061] The following are exemplary embodiments of the invention explained with reference to schematic drawings. These show:

[0062] Figures 1-18 Examples of an electronic

[0063] Drug packaging in different views, and

[0064] Figure 19 shows a flowchart for a process for manufacturing an electronic drug packaging according to Figures 1-18.

[0065] Elements or features of the same construction or function are marked with the same reference symbols across all figures. For the sake of clarity, not all depicted elements or features may be marked with their corresponding reference symbols in all figures, and / or not all elements or features may be shown in all figures.

[0066] Figures 1 to 18 show various schematic views of embodiments of an electronic drug packaging or components thereof. The electronic drug packaging comprises a foldable packaging unit 10 with a carrier layer 11, which is made, for example, of cardboard. The carrier layer 11 has a plurality of recesses 14 and die-cut areas 15, which are formed opposite each other in the carrier layer 11 with respect to a fold line 17 of the packaging unit 10. The recesses 14 are designed as die-cuts and create holes or openings to each receive a drug blister 2 (see Figure 15). The packaging unit 10 also has an adhesive layer 12, which covers a predefined surface of the carrier layer 11, forming an inner surface when the drug packaging is folded.The packaging unit 10 also has a covering layer 13 which covers the adhesive layer 12 as specified (see Figures 3 and P2024,0686 WO N / 24008P-WO 2 September 2025.

[0067] - 16 -

[0068] 6) The covering layer 13 can also be referred to as liner 13 and is designed, for example, as silicone paper.

[0069] The drug packaging further comprises an electronic label 30, which has a carrier layer 31, for example, designed as a foil element. The label 30 further comprises an electronic unit 33 and a plurality of conductive traces 34 (see Figures 1 and 5), which are spaced apart from one another. The label 30 is coupled to the carrier layer 11 of the packaging unit 10 such that at least one conductive trace 34 of the label 30 is assigned to each respective die-cut area 15 of the packaging unit 10, and the respective conductive trace 34 crosses the assigned die-cut area 15 of the packaging unit 10, at least partially. The label 30 thus implements an integrated circuit applied to a substrate. The label 30 can also be referred to as an insert card, which can be bonded to the packaging unit 10 by means of the adhesive layer 12 and / or by means of its own adhesive layer 32.

[0070] By peeling off the liner 13, the adhesive layer 12 can be exposed and by folding along the fold line 17, the packaging unit 10 can then be glued to itself, so that the recesses 14 and the punched areas 15 are arranged one above the other with respect to a stacking direction R of the drug packaging and overlap at least partially (see Figures 6, 8 and 15).

[0071] Packaging unit 10 has a first section 25 and a second section 26, which are separated, for example, by the fold line 17. When the drug packaging is folded, the first section 25 then forms, for example, a bottom and the second section 26 a top of the drug packaging, or vice versa.

[0072] As shown in Figure 1, the adhesive layer 12 is applied to the second section 26 and can be folded over the label 30 and the conductive traces 34, covering them, so that, in conjunction with the first section 25, the label 30 is reliably and securely embedded in the packaging unit 10. Alternatively, the adhesive layer 12 can be applied over the entire surface of the inside of the carrier layer 11 (see P2024,0686 WO N / 24008P-WO 2 September 2025).

[0073] - 17 -

[0074] Figure 2). The adhesive layer is designed in particular such that the carrier layer 11 can be bonded to itself at room temperature after removal of the covering layer 13 and by means of folds along the fold line 17. Such a seal can also be referred to as a cold seal, in contrast to a hot seal, where, for example, additional heat is required to melt a hot melt adhesive.

[0075] The drug packaging or packaging unit 10 can have two, three, or more recesses 14 and associated punched areas 15. The punched areas 15 are formed by punching and surround a respective area designed for removing the drug located in the opposite recess 14 (see Figure 15). The label 30 can be positioned between the punched areas 15 or, depending on the size of the punched areas 15, be large enough to cover them (see Figures 3 to 5). To facilitate opening, the label 30 preferably has perforations 36 that overlap the punched areas 15, allowing the drug to be easily pushed out of its blister 2 through the label 30 and the punched area 15 and removed from the drug packaging.

[0076] The medication, for example in the form of a liquid in a container 3, passes through the packaging unit 10 when it is squeezed out of a cavity 4 of the blister 2 and causes damage or a break in the associated conductive track 34. The respective conductive track 34 can cross the associated punched area 15 once or several times. The respective conductive track 34 can cross the associated punched area 15 in a straight line, in a zigzag pattern, or in a wave pattern. It should be ensured in each case that the medication cannot be forced past the respective conductive track 34 without being damaged. Damage to the conductive track 34 is then detected by the electronic unit 33 as a change in resistance or conductivity.In such an event, for example, a time stamp and a position are stored in the electronic unit 33, indicating from which cavity 4 the medication was taken. The electronic unit 33 is specifically designed to detect any interruption or change in the conductor tracks 34 and store it as an event. The stored events can then be read using a reader, such as an RFID reader P2024,0686 WO N / 24008P-WO 2 September 2025.

[0077] - 18 - or even a smartphone with the necessary reading capability. This allows for electronic verification of adherence to a prescribed medication plan.

[0078] Figures 3 to 5 show a system 1 comprising the drug packaging and at least one container 3 with a drug inside. The packaging unit 10 can have further fold lines 18 and 19, allowing the drug packaging to be folded further to reduce the lateral expansion of the folded drug packaging. Figure 3 shows the unfolded drug packaging, which has the cutouts 14 in the lower or second section 26 of the packaging unit 10 as die-cuts in the carton for the blisters 2. Figures 4 and 5 show the drug packaging folded once along fold line 17, which can optionally be folded further along fold lines 18 and 19. The fold lines 18 and 19 are preferably spaced apart from each other such that a flush-folded drug packaging can be formed in which the overlapping folded sections are substantially congruent.The distance between the fold lines 18 and 19 therefore corresponds essentially to the thickness of the double-folded drug packaging along the stacking direction R.

[0079] Figure 6 shows a schematic side view of the arrangement and coupling of the label 30 with the packaging unit 10. The packaging unit 10, comprising the carrier layer 11, the adhesive layer 12, and the liner 13, forms, for example, a self-adhesive envelope. According to this embodiment, the label 30 includes a circuit board, a chip, or an integrated circuit 39, which can be printed and thus constitute a printed circuit board. The integrated circuit 39 is coupled to the conductive traces 34, which are covered by an insulating layer 35, by means of a conductive adhesive layer 38. The insulating layer 35 is accordingly arranged between the layer with conductive traces 34 and the integrated circuit 39. The conductive adhesive layer 38 can be integrated within the insulating layer 35. The insulating layer 35 can be applied as an insulating varnish to the conductor tracks 34 or to the carrier layer 31 and cover a large part of the area of ​​the conductor tracks 34.The label 30 can further have an adhesive layer 32 for easy application, which is arranged on an underside of the carrier layer 31 with respect to the stacking direction R. P2024,0686 WO N / 24008P-WÖ 2 September 2025.

[0080] - 19 -

[0081] Label 30 primarily performs the functions of electronically monitoring medication dispensing. Detection of the opening of the medication packaging and the removal of a medication triggers a rupture of the associated conductive trace 34. Furthermore, after being attached to the packaging unit 10, label 30 covers a predetermined section of the self-adhesive layer and neutralizes it instead of the liner 13. To attach label 30, the adhesive layer 32 is exposed if it was previously covered.

[0082] The liner 13 has a first, inner die-cut 21 and a second, outer die-cut 22 that surrounds the first die-cut 21 (see Figures 3 to 6). The inner and outer die-cuts 21, 22 thus create an inner liner section 23, an outer liner section 24, and an intermediate liner frame 20. The liner 13, with its die-cuts 21, 22, is designed to correspond to the label 30 such that the inner liner section 23 is identical in shape but smaller in area than the label 30. After removing the inner liner from section 23, the underlying section of the adhesive layer 12 is exposed, and the label 30 can be easily and reliably bonded to the packaging unit 10, so that the label 30 covers at least part of the liner frame 20 (see Figure 6). The adhesive layer 32 of the label 30 comes into contact with the adhesive layer 12 of the packaging unit 10 and also with a top surface of the liner frame 20.Thus, label 30 can be coupled to packaging unit 10. The outer liner section 24 remains on packaging unit 10 and is removed when the blister(s) 2 are sealed.

[0083] If the adhesive layer 12 of the packaging unit 10 is also provided at the position where the label 30 is to be applied, the label 30 can be designed without an adhesive layer 32. Alternatively, if the label 30 has the adhesive layer 32, the adhesive layer 12 of the packaging unit 10 can be provided such that it is not present at the position where the label 30 is to be applied. At least one of the packaging unit 10 and label 30 preferably has an associated adhesive layer 12, 32, which enables simple and reliable bonding. Accordingly, one or two covering sections 13 are provided that cover the associated adhesive layer 12, 32. Perforations and / or die-cuts of the label P2024,0686 WO N / 24008P-WO 2 September 2025

[0084] - 20 -

[0085] 30 and the packaging unit 10, such as the punching areas 14, 15, 36, 43, are therefore preferably provided accordingly in the associated liner 13.

[0086] In a further processing step of the electronic drug packaging, the medications in containers 3 and blisters 2 are placed in the respective recesses, and the outer liner section 24 is peeled back to expose an outer area of ​​the adhesive layer 12. The packaging unit 10 is folded along the fold line 17 and adhered to itself. The label 30, which is positioned on the liner frame 20, is then embedded within the packaging unit 10. The liner frame 20 thus remains inside the packaging unit 10.

[0087] The first die-cut 21 thus defines an area of ​​the liner 13 that is removed before the label 30 is applied. The label 30, coupled with the packaging unit 10, can then be delivered to the customer. The second die-cut 22 is slightly larger than the label 30 and defines the portion of the adhesive backing or liner 13 that is removed during an assembly process. The first and second die-cuts 21, 22 can be parallel to each other. The liner frame 20 accordingly forms a strip-shaped ring of constant width. The two die-cuts 21, 22 can, for example, be spaced 2 to 5 mm apart. This dimension is determined specifically in relation to the label 30 to accommodate manufacturing tolerances and can vary from design to design.Alternatively, the first and second die-cuts 21, 22 can also run differently, so that the liner frame 20 does not have a consistently constant width.

[0088] The liner frame 20 has fulfilled its purpose and therefore remains in the final product. During the processing of the pharmaceutical packaging, the liner frame 20 allows for compensation of positional variations and facilitates further processing during assembly. In addition to the two die-cuts 21 and 22, the liner 13, the carrier layer 11, and the adhesive layer 12 are preferably die-cut along one outer edge using a single die-cutting tool. P2024,0686 WO N / 24008P-WO September 2, 2025

[0089] - 21 -

[0090] Figures 7 and 8 schematically show an embodiment of the drug packaging. Figure 7 shows a schematic top view, and Figure 8 shows a schematic sectional view in a side view along the conductive traces 34. The liner 13 has a specially shaped inner die 21, which contributes to reinforcement in the folding area of ​​the packaging unit 10 in order to prevent or counteract breakage of the conductive traces 34 in the respective folding area. In Figure 7, it is schematically indicated that conductive traces 34 cross the fold lines 18, 19 (see Figure 5), so that when the drug packaging is folded along the fold lines 18, 19, the crossing conductive traces 34 are creased, and therefore there is a risk of damage in this area. To reduce this risk, the inner, first die 21 is designed such that wider liner sections 27 are provided in the area of ​​the folding points.

[0091] The liner sections 27 remain as parts of the liner frame 20 between the inner die-cut 21 and the outer die-cut 22 after the inner and outer liner sections 23, 24 have been removed from the packaging unit 10. This provides an additional reinforcing layer at the respective fold points, making the structure of the drug packaging more stable at these critical locations. No additional layer is required for reinforcement; instead, sections of the liner 13, which is already present to cover the adhesive layer 12, can be used. The width of the reinforcement, or rather the liner section 27 at the fold point along the fold lines 18, 19, results, for example, from the width of the intersecting conductor tracks 34 and a predetermined overhang of a few millimeters.The width of the liner section 27 along the fold lines 18, 19 in Figure 7, for example, is in the range of 10–50 mm to form a reliable and stable crease reinforcement. Such a reinforced crease area is particularly useful in drug packaging layouts that have a crease and conductor tracks 34 running over it. In alternative layouts, a reinforcing liner section 27 may not be required.

[0092] Figures 9 and 10 schematically show another example of the drug packaging design. Figure 9 shows a schematic top view, and Figure 10 shows a schematic sectional view in a side view along a central axis. P2024,0686 WO N / 24008P-WÖ 2 September 2025

[0093] - 22 -

[0094] Label 30 can have a ring or frame shape, so that in a central area, a further section of the liner 13 initially remains, surrounded by the frame-shaped label 30. Accordingly, the liner 13 is formed with the first and second liner die-cuts 21, 22, which define the liner frame 20. Additionally, the liner 13 is formed in a central area with further first and second liner die-cuts 41, 42, which define another liner frame 40. The remaining liner frames 20 and 40 thus also define a ring- or frame-shaped section of the liner 13, which is designed to fit the label 30. When applying or affixing the label 30, the section of the liner 13 that is designed to fit the label 30 is first removed. The remaining outer and inner sections of liner 13 are then peeled off at the customer's site or during the assembly of the drug packaging.

[0095] The medication packaging may also include a child-resistant feature. An opening section 16 may be provided in the packaging unit 10, which enables medication removal (see Figures 3 to 5). A child-resistant mechanism may be based on the following steps in the patient's handling: The opening section 16 can be a semicircular cardboard section, a so-called "push tab," which is pressed through. Subsequently, a cover on the opposite side of the packaging unit 10 can be torn off, thus allowing removal of the medication.

[0096] If such a child-resistant feature is integrated into the medication packaging, it is advantageous to provide special perforation structures 37 in the film element 31 of the label 30 at the point covering the respective opening section 16. These structures facilitate easy handling during assembly (see Figure 11). Compared to a solid label film, this makes it easier to push through the opening section 16. Furthermore, such perforation structures 37 can also be provided independently of any integrated child-resistant feature in the medication packaging to allow for easy and controlled pushing of the medication through the layers of the packaging unit 10 and the label 30. Figures 12 to 14 show possible planar perforation structures 37, which are designed as semicircular or ring-shaped cut-and-bridge structures. The carrier layer 31 of the label 30 P2024,0686 WO N / 24008P-WO 2 September 2025

[0097] - 23 - tears in a controlled manner when pressed through in the area of ​​the perforation structure 37. The perforation structure 37 and / or the perforation 36 are preferably substantially congruent with the die-cut areas 15 of the carrier layer 11 of the packaging unit 10. In addition, due to the planar perforation structure 37 according to Figures 12 to 14, positional variations of the label 10 relative to the packaging unit 10 within manufacturing tolerances can be taken into account and contribute to a simplified opening process compared to a simple semicircular perforation line.

[0098] Figure 15 shows a schematic side view of two containers 3 arranged in cavities 4 of corresponding blisters 2 within the drug packaging. Due to the described design, the drug packaging can be sealed at room temperature, thus cold-sealing. Each container 3 and its drug contents are thereby protected from unwanted heat exposure, thus contributing to the preservation of drug efficacy, particularly for heat-sensitive active ingredients. When needed, the container 3, with the drug it contains, can be pushed out of the cavity 4 and through the layers of the drug packaging, following the direction of the arrow shown, and then removed. This process destroys the associated conductive trace 34, and the removal event is electronically detected and stored along with the corresponding information.

[0099] Figure 16 shows a schematic side view of another embodiment of the drug packaging, in which the electronic unit 33 is also arranged in a cavity 6 and covered by a cover 5. Such a cover 5 can be positioned on a surface of the packaging unit 10 that forms the inside when the drug packaging is folded. Alternatively, the cover 5 can be positioned on a surface of the packaging unit 10 that forms the outside when the drug packaging is folded. In each case, the electronic unit 33 is protected by the cover 5, which also prevents the glued sections 25, 26 of the packaging unit 10 from being forced apart. P2024,0686 WO N / 24008P-WO 2 September 2025

[0100] - 24 -

[0101] The self-adhesive bonding of the packaging unit 10 carries the risk that the adhesives may not form a permanent bond due to restoring and / or compressive forces. The electronic unit 33 can be embedded as a circuit board between the cardboard layers of the folded packaging unit 10, so that its dimensions exert restoring forces which push the cardboard layers apart and counteract a permanent bond. The deep-drawn cavity 6 in the cover 5 is specifically adapted to the shape of the electronic unit 33 and counteracts the separation of the cardboard layers. The electronic unit 33 can thus be accommodated in the drug packaging without tension.Alternatively or additionally, the label 30 can be designed and / or positioned so that it is connected to the packaging unit 10 relatively far away from an outer edge, so that a larger edge area can be provided for gluing the packaging unit 10 and enables a particularly reliable adhesive connection.

[0102] Figure 17 shows a further embodiment for forming an electronic drug packaging that can be set up without folding. The label 30 is designed for a corresponding packaging unit 10, which has recesses 14 for receiving blisters 2 and / or containers 3, such as syringes (see Figure 18). The packaging unit 10 can, in particular, be configured as a standard syringe package, in which the label 30 enables simple and cost-effective electronic retrofitting. The label 30 has, as an alternative or additional feature to the carrier layer 11, a further carrier layer 44, which is, for example, designed as a cardboard layer. The label 30 with the cardboard carrier layer 44 can also be referred to as a cardboard insert. The carrier layer 44 can be configured analogously or similarly to the first section 25 of the packaging unit 10.If the label 30 has its own adhesive layer 32, this can be provided on a surface of the carrier layer 11 and / or the carrier layer 44 and be covered with an associated liner 13, alternatively or additionally to the liner 13 of the packaging unit 10.

[0103] The label 30, in accordance with the packaging unit 10 and the number of blisters 2 or containers 3, comprises three die-cut areas 43, which extend through the respective carrier layer 31 and / or 44 and the liner 13, which covers the associated carrier layer 31 and / or 44. The die-cuts, which define the die-cut areas 43 P2024,0686 WO N / 24008P-WO 2 September 2025

[0104] - 25 - designed to allow for easy and controlled tearing and are coordinated with the conductor tracks 34 so that these are not damaged. The three die-cut areas 43 each provide tear strips with grip tabs which are torn open when a syringe 3 is removed from a corresponding recess 14, thereby destroying the corresponding conductor track 34. To grip the syringe 3, the carrier layer 44 of the label 30 has a die-cut 45 which, like a viewing window, allows a predetermined, limited access to the syringes 3.

[0105] The carrier layer 31, with the electronic unit 33 and the conductive traces 34 located thereon, is preferably arranged on an underside or inner side of the carrier layer 44, in particular by adhesive bonding. In the normal operating state of the medication packaging, the inner side faces the syringes 3. Thus, the circuit elements are protected by the cardboard layer of the carrier layer 44 above it. The die-cut areas 43 indicated in Figures 17 and 18 extend through the carrier layer 31 and / or the carrier layer 44 and a liner 13 that covers the adhesive layer 32. The carrier layer 11 and / or the carrier layer 44 can have the adhesive layer 32, which can be exposed as needed along the liner die-cuts 21, 22. Figure 17 illustrates how the inner liner section 23 is removed and the carrier layer 31 with the circuit elements is bonded to the carrier layer 44.

[0106] For adhesive attachment of the label 30 to the packaging unit 10 according to Figure 18, the remaining liner 13 is peeled away from the carrier layer 44 around the carrier layer 31, thus exposing further sections of the adhesive layer 32. This allows the label 30 to be easily and reliably adhered to the packaging unit 10 as an insert, forming an electronic drug packaging. The adhesive layer 32 is specifically designed to match the intended surface of the carrier layer 11 of the packaging unit 10, so that, when adhered, the adhesive layer 32 is preferably located only between the carrier layer 44 of the label 30 and the carrier layer 11 of the packaging unit 10 and does not extend undesirably into the area of ​​the syringes 3 or recesses 14. P2024,0686 WO N / 24008P-WO 2 September 2025

[0107] - 26 -

[0108] A standard packaging process for the syringes 3 can be retained, and only at the end of the manufacturing process of the electronic drug packaging is the remaining liner 13 removed and the label 30, in the form of an insert card, sealed in at room temperature. The remaining areas of the liner 13, as shown in Figure 17, are thus preferably removed only when the insert card or label 30 is to be attached to the packaging unit 10, for example, in the form of a syringe box as shown in Figure 18. The carrier layer 44 can, as shown in Figure 17, have an additional cardboard flap that can be folded over to protect the circuit board or the electronic unit 33. Alternatively, instead of such a cardboard flap, the area intended for the electronic unit 33 can be covered with a separate piece of cardboard or similar material.A protective cover for the electronic unit 33 can be useful, but is not absolutely necessary, as it is not freely accessible when glued in place.

[0109] A process for manufacturing a configuration of the electronic drug packaging can be carried out according to the flowchart in Figure 19. In step S1, the foldable packaging unit 10 is provided, which, for example, has a cardboard layer as a carrier layer 11 and the liner 13 with the first, inner and the second, outer die-cut 21 22.

[0110] In a further step S2, the electronic label 20 is provided, which, for example, has a film as a carrier layer 31 on which the conductor tracks 34 are formed.

[0111] In a further step S3, the label 30 is coupled to the cardboard layer of the packaging unit 10 by peeling off the inner liner section 23 and exposing the adhesive layer 12 underneath, and by adhering the label 30 to the liner frame 20, so that at least one conductor track 34 of the label 30 is assigned to each die-cut area 15 of the packaging unit 10, and the respective conductor track 34 crosses the assigned die-cut area 15 of the packaging unit 10 at least partially. P2024,0686 WO N / 24008P-WO 2 September 2025

[0112] - 27 -

[0113] In an optional further step S4, the medication packaging can be filled with medication and sealed by placing one or more containers 3 with medication contents in corresponding blisters 2 into the respective recesses 14 and peeling back the outer covering section 24, thereby exposing the corresponding section of the adhesive layer 12 of the packaging unit 10. By folding the packaging unit 10 along the fold line 17, the packaging unit 10 adheres to itself, and the label 30, which is positioned on the liner frame 20, is embedded in the packaging unit 10. The medication packaging is thus cold-sealed and ready for use by the patient.

[0114] The described electronic medication packaging enables reliable and cost-effective medication withdrawal tracking. The medication packaging provides a smart packaging envelope or intelligent packaging bag for medications and, via label 30, allows for electronic monitoring of medication withdrawal, which is then recorded in the

[0115] Packaging unit 10 are arranged and inserted into the designated recesses 14. The electronic drug packaging can also be referred to as smart drug packaging or smart wallet.

[0116] P2024,0686 WO N / 24008P-WO September 2, 2025

[0117] - 28 -

[0118] Reference symbol list

[0119] 1 system

[0120] 2 blisters

[0121] 3 Containers / Syringes

[0122] 4 Cavity for the vessel

[0123] 5 Cover for the electronics unit

[0124] 6 cavities for the electronics unit

[0125] 10 packaging units

[0126] 11 Carrier layer of the packaging unit

[0127] 12 Adhesive layer of the packaging unit

[0128] 13 Covering layer / Liner

[0129] 14 Exclusion of the packaging unit

[0130] 15. Punching area of ​​the packaging unit

[0131] 16 Opening section of the packaging unit

[0132] 17 first fold line

[0133] 18 second fold line

[0134] 19 third fold line

[0135] 20 liner frames

[0136] 21 first, inner liner die-cut

[0137] 22 second, outer liner die-cut

[0138] 23 inner liner section

[0139] 24 outer liner section

[0140] 25 first section of the packaging unit

[0141] 26 second section of the packaging unit

[0142] 27 Liner section

[0143] 30 electronic labels / electronic inserts

[0144] 31 Label carrier layer

[0145] 32 Adhesive layer of the label

[0146] 33 Electronic unit / RFID transponder

[0147] 34 conductor track of the label

[0148] 35 Insulation layer of the label

[0149] 36 Perforation P2024,0686 WO N / 24008P-WO September 2, 2025

[0150] - 29 -

[0151] 37 Perforation structure

[0152] 38 conductive adhesive layers

[0153] 39 Circuit / RFID chip

[0154] 40 additional liner frames 41 first, inner additional liner die-cut

[0155] 42 second, outer further liner die-cut

[0156] 43 Die-cutting area of ​​the label / insert

[0157] 44 additional carrier layer of the label / insert

[0158] 45 punching

[0159] R Stacking direction of the packaging unit / electronic label

[0160] S(i) Steps of a procedure for coupling a packaging unit with an electronic label

Claims

P2024,0686 WO N / 24008P-WO September 2, 2025 - 30 - Patent claims 1. Electronic drug packaging, comprising: - a packaging unit (10) with a carrier layer (11) comprising a plurality of recesses (14) and punched areas (15) which are formed opposite each other in the carrier layer (11) with respect to a fold line (17) of the packaging unit (10), wherein the recesses (14) are each designed to receive a blister (2), and - an electronic label (30) comprising a carrier layer (31, 44), an electronic unit (33) and a plurality of conductive traces (34) spaced apart from one another, wherein the label (30) is coupled to the carrier layer (11) of the packaging unit (10) such that at least one conductive trace (34) of the label (30) is assigned to each die-cutting area (15) of the packaging unit (10) and the respective conductive trace (34) crosses the assigned die-cutting area (15) of the packaging unit (10) at least sectionally, wherein the packaging unit (10) further comprises an adhesive layer (12) that covers a surface of the carrier layer (11) of the packaging unit (10) in a predetermined manner, and a covering layer (13) that covers the adhesive layer (12) in a predetermined manner,so that by peeling off the covering layer (13) the adhesive layer (12) can be exposed and by folding along the fold line (17) the packaging unit (10) can be glued to itself and the recesses (14) and the die-cut areas (15) can be arranged one above the other with respect to a stacking direction (R) of the drug packaging and overlap at least partially.

2. Electronic drug packaging, comprising: - a packaging unit (10) with a carrier layer (11) comprising a plurality of recesses (14) which are formed side by side in the carrier layer (11) with respect to a lateral extent of the packaging unit (10), wherein the recesses (14) are each designed to receive a blister (2) and / or container (3), and - an electronic label (30) comprising a carrier layer (31, 44), an electronic unit (33) and a plurality of conductor tracks (34) spaced apart from one another, wherein the label (30) comprises a plurality of P2024,0686 WO N / 24008P-WO September 2, 2025 - 31 - The label (30) comprises die-cut areas (43) which are arranged side by side with respect to a lateral extent of the label (30) in accordance with the recesses (14) of the packaging unit (10), and wherein at least one conductor track (34) is assigned to each die-cut area (43) of the label (30) and the respective conductor track (34) crosses the assigned die-cut area (43) at least partially, wherein at least the label (30) or the packaging unit (10) has an adhesive layer (12, 32) which covers a surface of the associated carrier layer (11, 31, 44) of the packaging unit (10) or the label (30) in a predetermined manner and which in turn is covered with a covering layer (13) in a predetermined manner, such that the adhesive layer (12, 32) can be exposed by peeling off the covering layer (13) and the packaging unit (10) can be affixed with the label (30) is adhesive,so that the cutouts (14) and the punched areas (43) can be arranged one above the other with respect to a stacking direction (R) of the drug packaging and overlap at least partially.

3. Electronic drug packaging according to one of the preceding claims, wherein the adhesive layer (12) of the packaging unit (10) is designed such that the carrier layer (11) of the packaging unit (10) can be bonded to itself at room temperature after peeling off the covering layer (13) and by folding along the fold line (17).

4. Electronic drug packaging according to one of the preceding claims, wherein the adhesive layer (12) fully covers the surface of the carrier layer (11) of the packaging unit (10), the surface forming an inside of the packaging unit (10) which is arranged inside after the packaging unit (10) has been folded and self-adhesive.

5. Electronic drug packaging according to one of the preceding claims, wherein the packaging unit (10) has a first and a second section (25, 26) and is designed and coupled with the label (30) such that the label (30) is arranged and embedded between the two sections (25, 26) of the packaging unit (10) after the packaging unit (10) has been folded and self-adhesive. P2024,0686 WO N / 24008P-WO September 2, 2025 - 32 - 6. Electronic drug packaging according to one of the preceding claims, wherein the covering layer (13) has a first, inner die-cut (21) and a second, outer die-cut (22) surrounding the first die-cut (21), such that an inner covering section (23), an outer covering section (24) and an intermediate covering frame (20) are provided, wherein the covering layer (13) is designed in accordance with the label (30) such that the inner covering section (23) is smaller in area than the label (30) and the label (10) is adhered to the packaging unit (10) after the inner covering section (23) has been removed, such that the label (30) covers the covering frame (20) at least partially.

7. Electronic drug packaging according to claim 6, wherein the packaging unit (10) is self-adhesive after peeling off the outer covering section (24) and folding along the fold line (17), and the label (30) arranged on the covering frame (20) is embedded inside the packaging unit (10).

8. Electronic drug packaging according to one of the preceding claims, wherein the packaging unit (10) comprises an opening section (16) in the area of ​​the recesses (14) and / or punched areas (15) which provides a component of a child safety lock with respect to drug removal.

9. Electronic drug packaging according to one of the preceding claims, wherein the packaging unit (10) has further fold lines (18, 19) along which the packaging unit (10) is foldable, wherein the covering layer (13) has one or more die-cuts (21, 22) in alignment with the fold lines (17, 18, 19) and the conductor tracks (34), such that after peeling the covering layer (13) from the adhesive layer (12) of the packaging unit (10) a predetermined section (20, 27) of the covering layer (13) remains on the packaging unit (10), which provides a crease reinforcement for the conductor tracks (34) in the area of ​​one or more fold lines (17, 18, 19). P2024,0686 WO N / 24008P-WO September 2, 2025 - 33 - 10. Electronic drug packaging according to one of the preceding claims, wherein the electronic label (30) comprises a circuit board and / or an RFID transponder (33) with an RFID chip (39) and an antenna structure, which are signal-technically coupled to each other and to the conductor tracks (34).

11. Electronic drug packaging according to one of the preceding claims, wherein the label (30) is designed in accordance with the packaging unit (10) such that it covers at least part of one or more die-cut areas (15) of the packaging unit (10) and the carrier layer (31, 44) of the label (30) has a perforation (36, 37) in the respective covering section.

12. Electronic drug packaging according to claim 10, wherein the label (30) has a predetermined perforation structure (37) in the respective covering section, which, with respect to a view of the carrier layer (31, 44) of the label (30), establishes a ring-shaped or planar material weakening.

13. Electronic drug packaging according to one of the preceding claims, wherein the carrier layer (11) of the packaging unit (10) is made of cardboard or comprises a cardboard element.

14. Electronic drug packaging according to one of the preceding claims, wherein the carrier layer (31) of the label (30) is made of film or comprises a film element.

15. Electronic drug packaging according to one of the preceding claims, wherein the carrier layer (31) or a further carrier layer (44) of the label (30) is made of cardboard or comprises a cardboard element.

16. Electronic drug packaging according to one of the preceding claims, wherein the conductor tracks (34) and / or the electronic unit (33) are formed by printing or etching on the carrier layer (31, 44) of the label (30). P2024,0686 WO N / 24008P-WO September 2, 2025 - 34 - 17. Electronic drug packaging according to one of the preceding claims, wherein the electronic unit (33) is coupled to one or more conductor tracks (34) by means of an electrically conductive adhesive layer (38).

18. System (1), comprising: - a container (5) for a drug, and / or - a blister pack (2) for the container (5), and - an electronic drug packaging according to one of the preceding claims, wherein the vessel (5) and / or the blister (2) are arranged in a recess (14) of the packaging unit (10).

19. System (1) according to claim 18, wherein the packaging unit (10) is glued to itself after peeling off the covering layer (13) and folding along the fold line (17), such that the recesses (14) and the punched areas (15) of the packaging unit (10) are arranged one above the other with respect to a stacking direction (R) of the drug packaging and overlap at least section by section.

20. System (1) according to claim 18, wherein the packaging unit (10) and the label (30) are bonded together after removal of the covering layer (13) and exposure of the associated adhesive layer (12, 32), such that the recesses (14) of the packaging unit (10) and the die-cut areas (43) of the label (30) are arranged one above the other with respect to a stacking direction (R) of the drug packaging and overlap at least section by section.

21. System (1) according to any one of claims 18 to 20, wherein the blister (2) has a cavity (4) in which the vessel (5) is arranged, such that the vessel (5) is embedded between the blister (2) and the packaging unit (10) and / or the label (30).

22. Method for manufacturing an electronic drug packaging, comprising: P2024,0686 WO N / 24008P-WO September 2, 2025 - 35 - - Providing a foldable packaging unit (10) with a carrier layer (11) comprising a plurality of recesses (14) and die-cut areas (15) formed opposite each other in the carrier layer (11) with respect to a fold line (17) of the packaging unit (10), wherein the recesses (14) are each designed to receive a blister (2), and wherein the packaging unit (10) further comprises an adhesive layer (12) which covers a surface of the carrier layer (11) of the packaging unit (10) in a predetermined manner, and a covering layer (13) which covers the adhesive layer (12) in a predetermined manner, - Providing an electronic label (30) comprising a carrier layer (31, 44), an electronic unit (33) and a plurality of conductor tracks (34) spaced apart from each other, - Coupling the label (30) to the carrier layer (11) of the packaging unit (10) by means of the adhesive layer (12), such that at least one conductor track (34) of the label (30) is assigned to each die-cutting area (15) of the packaging unit (10) and the respective conductor track (34) crosses the assigned die-cutting area (15) of the packaging unit (10) at least section by section.

23. Method for manufacturing an electronic drug packaging, comprising: - Providing a packaging unit (10) with a carrier layer (11) comprising a plurality of recesses (14) formed side by side in the carrier layer (11) with respect to a lateral extent of the packaging unit (10), wherein the recesses (14) are each designed to receive a blister (2) and / or a container (3), - Providing an electronic label (30) comprising a carrier layer (31, 44), an electronic unit (33), and a plurality of conductive traces (34) spaced apart from one another, wherein the label (30) includes a plurality of die-cut areas (43) arranged side by side with respect to a lateral extent of the label (10) in accordance with the recesses (14) of the packaging unit (10), and wherein at least one conductive trace (34) is assigned to each die-cut area (43) of the label (30), and the respective conductive trace (34) crosses the assigned die-cut area (43) at least partially, wherein at least the label (30) or the packaging unit (10) has an adhesive layer (12, 32) P2024,0686 WO N / 24008P-WO September 2, 2025 - 36 - has a surface of the associated carrier layer (11, 31, 44) of the packaging unit (10) or the label (30) that is covered in a predetermined manner and which in turn is covered with a covering layer (13) that is predetermined, and - Coupling the label (30) to the packaging unit (10) by means of the adhesive layer (12, 32) such that at least one conductor track (34) of the label (30) is assigned to each recess (14) of the packaging unit (10) and the respective conductor track (34) crosses the assigned recess (14) of the packaging unit (10) at least section by section.

24. The method of claim 22, comprising: Removing the covering layer (13) and exposing the associated adhesive layer (12, 32) and subsequently folding the packaging unit (10) along the fold line (17) so that the packaging unit (10) is glued to itself and the recesses (14) and the punched areas (15) are arranged one above the other with respect to a stacking direction (R) of the drug packaging and overlap at least section by section.

25. Method according to any one of claims 22 to 24, comprising providing the packaging unit (10) and coupling the label (30) to the packaging unit (10): - Punching the covering layer (13) and forming a first, inner punch (21) and a second, outer punch (22) surrounding the first punch (21), such that an inner covering section (23), an outer covering section (24) and an intermediate covering frame (20) are formed, wherein the covering layer (13) is formed in accordance with the label (30) such that the inner covering section (23) is smaller in area than the label (30), and - Removing the inner covering section (23) and thereby partially exposing the adhesive layer (12) of the packaging unit (10) and subsequently applying the label (30) to the exposed part of the adhesive layer (12) so that the label (30) covers the covering frame (20) at least partially.

26. The method of claim 25, wherein the self-adhesive bonding of the packaging unit (10) comprises: P2024,0686 WO N / 24008P-WO September 2, 2025 - 37 - Removing the outer covering section (24) and thereby exposing the adhesive layer (12) of the packaging unit (10) and subsequently folding the packaging unit (10) along the fold line (17) so that the packaging unit (10) is glued to itself and the label (30) arranged on the covering frame (20) is embedded inside the packaging unit (10).

27. Method according to any one of claims 22 to 26, wherein providing the label (30) comprises: - Providing the carrier layer (31, 44) of the label (30) as a film element or a cardboard element, and - Printing of the conductor tracks (34) on the foil element or the cardboard element and / or the carrier layer (11) of the packaging unit (10).

Images